Réza Elaidi

2.9k citations
34 papers · 881 indexed · h-index 16
Topics
Renal cell carcinoma treatment (18 papers)Renal and related cancers (10 papers)Cancer Immunotherapy and Biomarkers (9 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Réza Elaidi

32 papers receiving 871 citations

Peers

Réza Elaidi
Comparison fields: 5 of 80
  • Pulmonary and Respiratory Medicine 527
  • Oncology 465
  • Molecular Biology 295
  • Cancer Research 224
  • Surgery 125
Replace Cinzia Ortega with:
Cinzia Ortega Italy
Marija Bojić Austria
Chihiro Kondoh Japan
Hadar Goldvaser Israel
Milena Perez Mak Brazil
Aline Guillot France
Liangping Xia China
Florian Kocher Austria
A. Robinson United Kingdom
Réza Elaidi relative to Cinzia Ortega Italy Cinzia Ortega's profile →
Citations per field
00.5×2.6×
Cinzia Ortega · 1×
Citations per year

Countries citing papers authored by Réza Elaidi

Since Specialization
Citations

This map shows the geographic impact of Réza Elaidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Réza Elaidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Réza Elaidi more than expected).

Fields of papers citing papers by Réza Elaidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Réza Elaidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Réza Elaidi. The network helps show where Réza Elaidi may publish in the future.

Co-authorship network of co-authors of Réza Elaidi

This figure shows the co-authorship network connecting the top 25 collaborators of Réza Elaidi. A scholar is included among the top collaborators of Réza Elaidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Réza Elaidi. Réza Elaidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 4
5 35
6 12
7 4
8 18
9 62
10 5
11 7
12 16
13 25
14 8
15 36
16 230
17 86
18 30
19 2
20 15

About Réza Elaidi

Réza Elaidi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 34 papers that have together received 881 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Renal and related cancers (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (465 citations), Pulmonary and Respiratory Medicine (527 citations) and Cancer Research (224 citations). Réza Elaidi has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Stéphane Oudard, Benoit Beuselinck, Yann Vano, Jessica Zucman‐Rossi, Jacques Médioni, Alexandra Karadimou, Constance Thibault, Florian Scotté, Arnaud Méjean and Patrick Schöffski. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026